Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
VASC's Cash to Debt is ranked higher than
98% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.42 vs. VASC: No Debt )
Ranked among companies with meaningful Cash to Debt only.
VASC' s Cash to Debt Range Over the Past 10 Years
Min: 1.11  Med: 10000.00 Max: No Debt
Current: No Debt
Equity to Asset 0.90
VASC's Equity to Asset is ranked higher than
93% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. VASC: 0.90 )
Ranked among companies with meaningful Equity to Asset only.
VASC' s Equity to Asset Range Over the Past 10 Years
Min: 0.34  Med: 0.87 Max: 0.96
Current: 0.9
0.34
0.96
Interest Coverage No Debt
VASC's Interest Coverage is ranked higher than
98% of the 195 Companies
in the Global Medical Devices industry.

( Industry Median: 38.74 vs. VASC: No Debt )
Ranked among companies with meaningful Interest Coverage only.
VASC' s Interest Coverage Range Over the Past 10 Years
Min: 48.63  Med: 1211.19 Max: 9999.99
Current: No Debt
48.63
9999.99
F-Score: 6
Z-Score: 35.60
M-Score: -2.41
WACC vs ROIC
9.31%
11.37%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 6.74
VASC's Operating margin (%) is ranked higher than
58% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 2.65 vs. VASC: 6.74 )
Ranked among companies with meaningful Operating margin (%) only.
VASC' s Operating margin (%) Range Over the Past 10 Years
Min: -8.18  Med: 13.25 Max: 17.33
Current: 6.74
-8.18
17.33
Net-margin (%) 6.22
VASC's Net-margin (%) is ranked higher than
61% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 1.06 vs. VASC: 6.22 )
Ranked among companies with meaningful Net-margin (%) only.
VASC' s Net-margin (%) Range Over the Past 10 Years
Min: -8.15  Med: 10.08 Max: 27.25
Current: 6.22
-8.15
27.25
ROE (%) 7.64
VASC's ROE (%) is ranked higher than
61% of the 297 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. VASC: 7.64 )
Ranked among companies with meaningful ROE (%) only.
VASC' s ROE (%) Range Over the Past 10 Years
Min: -31.56  Med: 13.33 Max: 72.44
Current: 7.64
-31.56
72.44
ROA (%) 6.79
VASC's ROA (%) is ranked higher than
70% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: -0.01 vs. VASC: 6.79 )
Ranked among companies with meaningful ROA (%) only.
VASC' s ROA (%) Range Over the Past 10 Years
Min: -16.48  Med: 11.29 Max: 42.87
Current: 6.79
-16.48
42.87
ROC (Joel Greenblatt) (%) 15.51
VASC's ROC (Joel Greenblatt) (%) is ranked higher than
62% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 4.86 vs. VASC: 15.51 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
VASC' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -28.47  Med: 39.66 Max: 56.54
Current: 15.51
-28.47
56.54
Revenue Growth (3Y)(%) 10.90
VASC's Revenue Growth (3Y)(%) is ranked higher than
75% of the 232 Companies
in the Global Medical Devices industry.

( Industry Median: 3.90 vs. VASC: 10.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
VASC' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 8.6  Med: 12.90 Max: 119
Current: 10.9
8.6
119
EBITDA Growth (3Y)(%) -2.80
VASC's EBITDA Growth (3Y)(%) is ranked lower than
59% of the 194 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. VASC: -2.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
VASC' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -61.4  Med: 0.90 Max: 265.1
Current: -2.8
-61.4
265.1
EPS Growth (3Y)(%) -1.10
VASC's EPS Growth (3Y)(%) is ranked lower than
55% of the 195 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. VASC: -1.10 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
VASC' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -67.4  Med: -14.75 Max: 22.1
Current: -1.1
-67.4
22.1
» VASC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

VASC Guru Trades in Q2 2015

Jim Simons 443,900 sh (+3.38%)
Mario Gabelli 240,100 sh (-3.79%)
Chuck Royce 163,500 sh (-5.65%)
Mairs and Power 91,353 sh (-20.13%)
» More
Q3 2015

VASC Guru Trades in Q3 2015

Jim Simons 484,400 sh (+9.12%)
Mario Gabelli 231,000 sh (-3.79%)
Chuck Royce 155,450 sh (-4.92%)
Mairs and Power 76,553 sh (-16.20%)
» More
Q4 2015

VASC Guru Trades in Q4 2015

Jim Simons 480,800 sh (-0.74%)
Mario Gabelli 229,200 sh (-0.78%)
Mairs and Power 69,853 sh (-8.75%)
Chuck Royce 114,485 sh (-26.35%)
» More
Q1 2016

VASC Guru Trades in Q1 2016

Mairs and Power 75,553 sh (+8.16%)
Jim Simons 496,700 sh (+3.31%)
Chuck Royce Sold Out
Mario Gabelli 227,200 sh (-0.87%)
» More
» Details

Insider Trades

Latest Guru Trades with VASC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:OTCPK:CSRMF, NAS:KTWO, OTCPK:MCRPF, NAS:MDXG, NAS:OFIX, NAS:CSII, NAS:SPNC, NYSE:ITGR, NAS:HTWR, NAS:INGN, NAS:XENT, NAS:ARAY, OTCPK:MZRTF, NYSE:IVC, NAS:GNMK, NAS:LDRH, OTCPK:NMRD, NYSE:CRY, NAS:EXAC, OTCPK:IPDQF » details
Traded in other countries:VA4.Germany,
Vascular Solutions Inc is a medical device company. It is engaged in providing solutions to interventional cardiologists and interventional radiologists.

Vascular Solutions Inc was incorporated in the state of Minnesota in December 1996. It is a medical device company, creates new minimally invasive medical devices, and delivers these products and related services to physicians through its direct domestic sales force and its international distribution network. The Company's products and services are divided into three categories: Catheter products; Hemostat products and Vein products and services. Catheter products consist principally of catheters used in minimally invasive medical procedures for the diagnosis or treatment of vascular conditions, such as the GuideLiner catheter used to access discrete regions of the coronary anatomy and the Pronto extraction catheters used in treating acute myocardial infarction. Hemostat products consist principally of blood clotting products, such as the D-Stat Dry hemostat, a topical thrombin-based pad with a bandage used to control surface bleeding, and the D-Stat Flowable, a thick yet flowable thrombin-based mixture for preventing bleeding in subcutaneous pockets. Vein products and services consist principally of the Vari-Lase endovenous laser, a laser console and procedure kit used for the treatment of varicose veins, and a reprocessing service for the ClosureFAST radiofrequency vein ablation catheter. The Company manufactures its products in its facilities located in the suburbs of Minneapolis, Minnesota and in the country of Ireland. The catheter manufacturing and packaging processes occur under a controlled clean room environment. It purchases components from various suppliers and rely on single sources for several parts of its products. It purchases its requirements for thrombin for use in manufacturing products sold in the U.S. under the Thrombin-JMI Supply Agreement with King. Its main competitors include: Medtronic, Boston Scientific, Covidien, Merit Medical, Marine Polymer Technologies, Cook Medical, Spectranetics, AngioDynamics and Terumo. The Company's products and services are regulated in the United States as medical devices by the FDA under the Federal Food, Drug and Cosmetic Act.

Ratios

vs
industry
vs
history
P/E(ttm) 84.36
VASC's P/E(ttm) is ranked lower than
90% of the 172 Companies
in the Global Medical Devices industry.

( Industry Median: 28.34 vs. VASC: 84.36 )
Ranked among companies with meaningful P/E(ttm) only.
VASC' s P/E(ttm) Range Over the Past 10 Years
Min: 5.09  Med: 25.52 Max: 447.5
Current: 84.36
5.09
447.5
Forward P/E 38.31
VASC's Forward P/E is ranked lower than
76% of the 55 Companies
in the Global Medical Devices industry.

( Industry Median: 24.63 vs. VASC: 38.31 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 84.36
VASC's PE(NRI) is ranked lower than
90% of the 171 Companies
in the Global Medical Devices industry.

( Industry Median: 28.88 vs. VASC: 84.36 )
Ranked among companies with meaningful PE(NRI) only.
VASC' s PE(NRI) Range Over the Past 10 Years
Min: 5.09  Med: 25.52 Max: 447.5
Current: 84.36
5.09
447.5
P/B 6.05
VASC's P/B is ranked lower than
77% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 2.95 vs. VASC: 6.05 )
Ranked among companies with meaningful P/B only.
VASC' s P/B Range Over the Past 10 Years
Min: 2.37  Med: 4.15 Max: 17.29
Current: 6.05
2.37
17.29
P/S 5.28
VASC's P/S is ranked lower than
65% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 3.51 vs. VASC: 5.28 )
Ranked among companies with meaningful P/S only.
VASC' s P/S Range Over the Past 10 Years
Min: 1.37  Med: 2.64 Max: 5.28
Current: 5.28
1.37
5.28
POCF 68.14
VASC's POCF is ranked lower than
97% of the 134 Companies
in the Global Medical Devices industry.

( Industry Median: 20.58 vs. VASC: 68.14 )
Ranked among companies with meaningful POCF only.
VASC' s POCF Range Over the Past 10 Years
Min: 9.25  Med: 16.15 Max: 83.57
Current: 68.14
9.25
83.57
EV-to-EBIT 73.50
VASC's EV-to-EBIT is ranked lower than
85% of the 172 Companies
in the Global Medical Devices industry.

( Industry Median: 22.17 vs. VASC: 73.50 )
Ranked among companies with meaningful EV-to-EBIT only.
VASC' s EV-to-EBIT Range Over the Past 10 Years
Min: -167.7  Med: 15.60 Max: 183.7
Current: 73.5
-167.7
183.7
EV-to-EBITDA 45.79
VASC's EV-to-EBITDA is ranked lower than
83% of the 181 Companies
in the Global Medical Devices industry.

( Industry Median: 18.09 vs. VASC: 45.79 )
Ranked among companies with meaningful EV-to-EBITDA only.
VASC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1229.7  Med: 13.10 Max: 1349.2
Current: 45.79
-1229.7
1349.2
PEG 17.58
VASC's PEG is ranked lower than
92% of the 74 Companies
in the Global Medical Devices industry.

( Industry Median: 3.18 vs. VASC: 17.58 )
Ranked among companies with meaningful PEG only.
VASC' s PEG Range Over the Past 10 Years
Min: 0.45  Med: 2.16 Max: 39.61
Current: 17.58
0.45
39.61
Shiller P/E 73.60
VASC's Shiller P/E is ranked lower than
69% of the 45 Companies
in the Global Medical Devices industry.

( Industry Median: 41.87 vs. VASC: 73.60 )
Ranked among companies with meaningful Shiller P/E only.
VASC' s Shiller P/E Range Over the Past 10 Years
Min: 41.86  Med: 57.45 Max: 572.5
Current: 73.6
41.86
572.5
Current Ratio 5.86
VASC's Current Ratio is ranked higher than
83% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.83 vs. VASC: 5.86 )
Ranked among companies with meaningful Current Ratio only.
VASC' s Current Ratio Range Over the Past 10 Years
Min: 1.94  Med: 5.35 Max: 26.32
Current: 5.86
1.94
26.32
Quick Ratio 4.20
VASC's Quick Ratio is ranked higher than
79% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. VASC: 4.20 )
Ranked among companies with meaningful Quick Ratio only.
VASC' s Quick Ratio Range Over the Past 10 Years
Min: 1.36  Med: 3.90 Max: 25.52
Current: 4.2
1.36
25.52
Days Inventory 153.56
VASC's Days Inventory is ranked lower than
57% of the 279 Companies
in the Global Medical Devices industry.

( Industry Median: 134.88 vs. VASC: 153.56 )
Ranked among companies with meaningful Days Inventory only.
VASC' s Days Inventory Range Over the Past 10 Years
Min: 130.39  Med: 152.01 Max: 182.03
Current: 153.56
130.39
182.03
Days Sales Outstanding 51.17
VASC's Days Sales Outstanding is ranked higher than
76% of the 270 Companies
in the Global Medical Devices industry.

( Industry Median: 68.74 vs. VASC: 51.17 )
Ranked among companies with meaningful Days Sales Outstanding only.
VASC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.41  Med: 50.18 Max: 54.98
Current: 51.17
47.41
54.98
Days Payable 42.80
VASC's Days Payable is ranked lower than
79% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 62.25 vs. VASC: 42.80 )
Ranked among companies with meaningful Days Payable only.
VASC' s Days Payable Range Over the Past 10 Years
Min: 21.44  Med: 37.58 Max: 43.39
Current: 42.8
21.44
43.39

Valuation & Return

vs
industry
vs
history
Price/Net Cash 39.66
VASC's Price/Net Cash is ranked lower than
77% of the 140 Companies
in the Global Medical Devices industry.

( Industry Median: 17.71 vs. VASC: 39.66 )
Ranked among companies with meaningful Price/Net Cash only.
VASC' s Price/Net Cash Range Over the Past 10 Years
Min: 0.58  Med: 24.29 Max: 539.5
Current: 39.66
0.58
539.5
Price/Net Current Asset Value 11.54
VASC's Price/Net Current Asset Value is ranked lower than
68% of the 249 Companies
in the Global Medical Devices industry.

( Industry Median: 7.14 vs. VASC: 11.54 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
VASC' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 0.49  Med: 6.83 Max: 28.94
Current: 11.54
0.49
28.94
Price/Tangible Book 7.00
VASC's Price/Tangible Book is ranked lower than
71% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 4.19 vs. VASC: 7.00 )
Ranked among companies with meaningful Price/Tangible Book only.
VASC' s Price/Tangible Book Range Over the Past 10 Years
Min: 0.48  Med: 4.99 Max: 16.59
Current: 7
0.48
16.59
Price/Projected FCF 4.24
VASC's Price/Projected FCF is ranked lower than
79% of the 129 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. VASC: 4.24 )
Ranked among companies with meaningful Price/Projected FCF only.
VASC' s Price/Projected FCF Range Over the Past 10 Years
Min: 1.34  Med: 2.15 Max: 130.33
Current: 4.24
1.34
130.33
Price/Median PS Value 1.99
VASC's Price/Median PS Value is ranked lower than
86% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.05 vs. VASC: 1.99 )
Ranked among companies with meaningful Price/Median PS Value only.
VASC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.31  Med: 1.14 Max: 12.76
Current: 1.99
0.31
12.76
Price/Graham Number 5.12
VASC's Price/Graham Number is ranked lower than
83% of the 147 Companies
in the Global Medical Devices industry.

( Industry Median: 2.28 vs. VASC: 5.12 )
Ranked among companies with meaningful Price/Graham Number only.
VASC' s Price/Graham Number Range Over the Past 10 Years
Min: 0.88  Med: 2.34 Max: 10.48
Current: 5.12
0.88
10.48
Earnings Yield (Greenblatt) (%) 1.40
VASC's Earnings Yield (Greenblatt) (%) is ranked higher than
58% of the 341 Companies
in the Global Medical Devices industry.

( Industry Median: -0.40 vs. VASC: 1.40 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
VASC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.5  Med: 5.60 Max: 10.3
Current: 1.4
0.5
10.3
Forward Rate of Return (Yacktman) (%) 3.03
VASC's Forward Rate of Return (Yacktman) (%) is ranked lower than
52% of the 117 Companies
in the Global Medical Devices industry.

( Industry Median: 7.42 vs. VASC: 3.03 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
VASC' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -57.3  Med: 2.30 Max: 54.1
Current: 3.03
-57.3
54.1

More Statistics

Revenue (TTM) (Mil) $155.6
EPS (TTM) $ 0.55
Beta1.03
Short Percentage of Float7.71%
52-Week Range $24.34 - 47.34
Shares Outstanding (Mil)17.49

Analyst Estimate


Warning: Invalid argument supplied for foreach() in /home/gurufocu/public_html/modules/stock/estimate.php on line 163
Dec16 Dec17
Revenue (Mil $) 165 183
EPS ($) 1.21 1.43
EPS w/o NRI ($) 1.21 1.43
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for NAS:VASC

Headlines

Articles On GuruFocus.com
Mairs & Power Comments on Vascular Solutions Dec 01 2015 
Vascular Solutions Inc. Reports Operating Results (10-K) Feb 01 2011 
Vascular Solutions Inc. (VASC) CEO Howard Root sells 25,000 Shares Nov 04 2010 
Vascular Solutions Inc. Reports Operating Results (10-K) Feb 02 2010 
Vascular Solutions Inc. Reports Operating Results (10-Q) Apr 17 2009 

More From Other Websites
Vascular Solutions to Present at the Canaccord Genuity Growth Conference Jul 27 2016
Vascular Solutions, Inc. :VASC-US: Earnings Analysis: Q2, 2016 By the Numbers : July 27, 2016 Jul 27 2016
5 Stocks Set to Rise on New Analyst Coverage Jul 27 2016
ETF’s with exposure to Vascular Solutions, Inc. : July 26, 2016 Jul 26 2016
Edited Transcript of VASC earnings conference call or presentation 25-Jul-16 8:30pm GMT Jul 25 2016
Vascular Solutions posts 2Q profit Jul 25 2016
Vascular Solutions posts 2Q profit Jul 25 2016
VASCULAR SOLUTIONS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 25 2016
Vascular Solutions Reports Second Quarter Results Jul 25 2016
Q2 2016 Vascular Solutions Inc Earnings Release - After Market Close Jul 25 2016
Medical Product Stocks Jul 25 Earnings Roster: CRY, VASC Jul 22 2016
Vascular Solutions downgraded by Sidoti Jul 12 2016
ETF’s with exposure to Vascular Solutions, Inc. : June 30, 2016 Jun 30 2016
Vascular Solutions, Inc. :VASC-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 Jun 28 2016
Vascular Solutions, Inc. to Webcast Second Quarter Conference Call Jun 27 2016
[$$] Bringing Justice to Justice Jun 05 2016
VASCULAR SOLUTIONS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 02 2016
VASCULAR SOLUTIONS INC Financials Apr 29 2016
ETF’s with exposure to Vascular Solutions, Inc. : April 28, 2016 Apr 28 2016
Vascular Solutions, Inc. :VASC-US: Earnings Analysis: Q1, 2016 By the Numbers Apr 27 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)